Lipocalin-2 (LCN2), secreted by reactive astrocytes, binds to astrocytic LCN2R and triggers iron-dependent ferroptosis of neighboring synapses. LCN2 elevation correlates with cognitive decline independent of amyloid burden, offering an amyloid-independent mechanism. However, the hypothesis suffers from multiple fundamental weaknesses: (1) LCN2R remains poorly characterized with questionable specificity; (2) no GWAS support for LCN2 or related iron metabolism genes in AD risk; (3) ferroptosis evidence comes from in vitro models with non-physiological iron concentrations; (4) LCN2 elevation may be an adaptive acute-phase response rather than a toxin; (5) iron chelation trials in AD showed limited efficacy, undermining the ferroptosis mechanism. The hypothesis received the lowest confidence from both the Skeptic (0.48) and is the least supported by human genetics.
Curated pathway from expert analysis
flowchart TD
A["LCN2 (Lipocalin-2)<br/>Iron-binding Protein"]
B["LRP2 (Megalin)<br/>Receptor-mediated Uptake"]
C["Intracellular<br/>Iron Accumulation"]
D["Oxidative<br/>Stress Response"]
E["Ferroptosis<br/>Execution"]
F["Neuronal<br/>Cell Death"]
G["Biomarker<br/>Neurodegeneration"]
A --> B
B --> C
C --> D
D --> E
E --> F
A --> G
F --> G
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for LCN2 yet. Search RCSB →
Median TPM across 13 brain regions for LCN2 from GTEx v10.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for LCN2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF LCN2 signaling is genetically ablated (LCN2 knockout or LCN2R CRISPR knockout) in 5xFAD mice at 6 months of age, THEN synaptic density in the hippocampus (measured by PSD-95 western blot and confoc | Significant preservation of excitatory synapse number and PSD-95 protein levels in LCN2-ablated AD mice relative to AD controls with intact LCN2 signaling | — no observation — | pending | 0.25 |
| IF human CSF LCN2 concentrations are measured at baseline in a cohort of amyloid-negative cognitively normal elderly subjects (n≥200, mean age 72), THEN subjects in the highest LCN2 tertile will show | LCN2 in the highest tertile predicts ≥1.5 point greater ADAS-Cog13 decline at 36 months and ≥0.5 point greater CDR-SB worsening, with beta-amyloid PET negativit | — no observation — | pending | 0.32 |